Treatment for MS within 6 months of the first demyelinating event improved EDSS scores, disability progression, and conversion to secondary progressive MS. “Although it is clear that disease-modifying treatment in MS reduces disability in the long...
1. In this randomized controlled trial, among ischemic stroke patients treated with intravenous thrombolysis, it was found that adjunctive intravenous argatroban or eptifibatide did not reduce disability 90 days post-stroke compared with placebo. 2. Symptomatic...
TUESDAY, Oct. 1, 2024 (HealthDay News) -- A new law just passed in California makes it the first state to tell public schools they may no longer serve foods that contain six artificial dyes linked to health and behavior problems among children.Gov. Gavin Newsom...
TUESDAY, Oct. 1, 2024 (HealthDay News) -- The incidence of severe injuries from powered micromobility devices increased from 2019 to 2022, according to a study published online Sept. 12 in the American Journal of Public Health.Kathryn G. Burford, Ph.D., from...
1. In this randomized controlled trial, in patients diagnosed with migraine, it was found that administration of a monoclonal antibody against pituitary adenylate cyclase-activating polypeptide (PACAP), Lu AG09222, was associated with a reduction in migraines...
MONDAY, Sept. 30, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, in combination with the enzyme inhibitor miglustat, is...
1. In this randomized controlled trial, among ischemic stroke patients treated with intravenous thrombolysis, it was found that adjunctive intravenous argatroban or eptifibatide did not reduce disability 90 days post-stroke compared with placebo. 2. Symptomatic...
TUESDAY, Oct. 1, 2024 (HealthDay News) -- A new law just passed in California makes it the first state to tell public schools they may no longer serve foods that contain six artificial dyes linked to health and behavior problems among children.Gov. Gavin Newsom...
TUESDAY, Oct. 1, 2024 (HealthDay News) -- The incidence of severe injuries from powered micromobility devices increased from 2019 to 2022, according to a study published online Sept. 12 in the American Journal of Public Health.Kathryn G. Burford, Ph.D., from...
1. In this randomized controlled trial, in patients diagnosed with migraine, it was found that administration of a monoclonal antibody against pituitary adenylate cyclase-activating polypeptide (PACAP), Lu AG09222, was associated with a reduction in migraines...
MONDAY, Sept. 30, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, in combination with the enzyme inhibitor miglustat, is...
A collection of feature articles, study abstracts, and additional resources all focused on tardive dyskinesia (TD).
The latest news from ACTRIMS Forum 2024 focused on multiple sclerosis, including abstracts, features, and helpful conference information.
The latest news from AAN 2023 Fall Conference on multiple sclerosis (MS), including featured articles and information about the conference.
The latest news from 2023 NACLC on non-small cell lung cancer (NSCLC), including abstracts, featured articles, and information about the conference.
Yvette C. Terrie, RPh, shares insights into addressing non-adherence and motivating patients to adhere to medication recommendations and health practices.
Patients have easy access to health information, so doctors must enhance efforts involving helping patients understand their conditions and treatment options.
In this medical fiction, a pampered heir's anti-antibiotic crusade ends after an encounter with a bear cub renders him a victim of his own misguided beliefs.
This course discusses whether progression independent of relapse activity in multiple sclerosis is linked with the rate of spinal cord atrophy and the burden of brain paramagnetic rim lesions.
Medical cartoon about ICD-10 codes raining down on the medical community during ICD-10-CM update season.
2025 ICD-10-CM updates include new codes, code deletions and revisions, and a conversion table that identifies inactive codes and their replacements.
Although a patient's request for a second opinion can make a physician question the patient’s trust level, physicians should consider supporting that desire.
Working in a concierge healthcare system allows doctors to reclaim their primary role in patient care and reconnect with meaning in their practice of medicine.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
